June 2026 ICU Medical launched the Plum Solo single-channel infusion pump in the United States following FDA clearance, expanding its connected infusion therapy portfolio with advanced interoperability, wireless connectivity, and streamlined medication delivery for acute care settings.
April 2026 Fresenius Kabi expanded its U.S. infusion portfolio by introducing new enhancements to the Ivenix Infusion System, strengthening smart infusion capabilities, cybersecurity, and hospital workflow integration.
January 2026 Medtronic received U.S. FDA approval for a manufacturing enhancement to its SynchroMed Infusion System, supporting continued production expansion and supply of implantable programmable infusion pumps.
September 2025 ICU Medical introduced new software and interoperability enhancements for the Plum Duo Infusion Pump, expanding integration with hospital electronic medical record systems and reinforcing its connected infusion management platform.